Valuation Bio-Techne Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
75.83 ^USD	-0.35%		+3.44%	+5.28%

Jan. 14	Bio-Techne Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM
Jan. 10	Bio-Techne Expands R&D Systems Ai-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine	CI

Data adjusted to current consolidation scope

Fiscal Period: June	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	10,094	17,511	13,600	12,852	11,291	12,049	-	-
Change	-	73.49%	-22.34%	-5.5%	-12.14%	6.71%	-	-
Enterprise Value (EV) ¹	10,179	17,621	13,609	12,997	11,457	11,947	11,636	11,287
Change	-	73.11%	-22.77%	-4.49%	-11.85%	4.28%	-2.61%	-3%
P/E ratio	45.4x	130x	52.3x	46.4x	68.2x	63.1x	48.4x	40.3x
PBR	7.53x	11.2x	8.36x	6.72x	5.48x	5.15x	4.54x	3.84x
PEG	-	-3.2x	0.6x	7.5x	-1.7x	4.4x	1.6x	2x
Capitalization / Revenue	13.7x	18.8x	12.3x	11.3x	9.74x	9.85x	9.01x	8.09x
EV / Revenue	13.8x	18.9x	12.3x	11.4x	9.88x	9.76x	8.7x	7.58x
EV / EBITDA	38x	45.7x	30.3x	29.5x	27.9x	28x	23.7x	21x
EV / EBIT	41.3x	48.7x	32.3x	31.7x	31x	31x	26x	22.6x
EV / FCF	66.4x	57.2x	48.5x	60.1x	48.5x	40.5x	31.2x	15.6x
FCF Yield	1.51%	1.75%	2.06%	1.66%	2.06%	2.47%	3.2%	6.39%
Dividend per Share ²	0.32	0.32	0.32	0.32	0.32	0.32	0.3333	0.32
Rate of return	0.48%	0.28%	0.37%	0.39%	0.45%	0.42%	0.44%	0.42%
EPS ²	1.455	0.8675	1.658	1.76	1.05	1.201	1.568	1.882
Distribution rate	22%	36.9%	19.3%	18.2%	30.5%	26.6%	21.3%	17%
Net sales ¹	738.7	931	1,106	1,137	1,159	1,224	1,337	1,489
EBITDA ¹	268.1	385.7	449.3	441	411	426.2	492	538.5
EBIT ¹	246.3	362.2	421.3	410.2	370.2	385.5	446.9	500.4
Net income ¹	229.3	140.4	272.1	285.3	168.1	197	261.2	319.8
Net Debt ¹	85.85	109.8	8.881	145.7	166.1	-101.7	-413.1	-761.7
Reference price ²	66.02	112.56	86.66	81.63	71.65	75.83	75.83	75.83
Nbr of stocks (in thousands)	152,892	155,567	156,934	157,437	157,585	158,892	-	-
Announcement Date	8/4/20	8/5/21	8/4/22	8/8/23	8/7/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
BIO-TECHNE CORPORATION	63.12x	9.76x	28.03x	+0.42%	12.05B
LONZA GROUP AG	47.27x	6.53x	23.18x	+0.81%	43.8B
IQVIA HOLDINGS INC.	26.87x	3.13x	13.09x	-.--%	35.82B
CELLTRION, INC.	89.6x	11.27x	40.49x	+0.26%	26.23B
ICON PUBLIC LIMITED COMPANY	22.74x	2.29x	10.96x	-.--%	16.36B
UNITED THERAPEUTICS CORPORATION	14.55x	4.82x	9.25x	-.--%	16.02B
MODERNA, INC.	-3.63x	1.68x	-1.5x	-.--%	13.11B
MEDPACE HOLDINGS, INC.	28.2x	4.87x	22.34x	-.--%	10.46B
QIAGEN N.V.	62.18x	5.29x	14.32x	-.--%	10.22B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	27.68x	2.59x	10.47x	-.--%	8.36B
Average	37.86x	5.22x	17.06x	+0.15%	19.24B
Weighted average by Cap.	40.86x	5.58x	19.01x	+0.25%